DEWPOINTX Trademark

Trademark Overview

On Wednesday, November 25, 2020, a trademark application was filed for DEWPOINTX with the United States Patent and Trademark Office. The USPTO has given the DEWPOINTX trademark a serial number of 90342745. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 27, 2023. This trademark is owned by Dewpoint Therapeutics, Inc.. The DEWPOINTX trademark is filed in the Chemical Products category with the following description:

Reagents for research use; reagents for research purposes in the field of drug discovery and development; diagnostic reagents for clinical laboratory use
dewpointx

General Information

Serial Number90342745
Word MarkDEWPOINTX
Filing DateWednesday, November 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2021

Trademark Statements

Pseudo MarkDEW POINT X
Goods and ServicesReagents for research use; reagents for research purposes in the field of drug discovery and development; diagnostic reagents for clinical laboratory use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, February 2, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDewpoint Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameDewpoint Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, March 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 12, 2022SOU EXTENSION 2 GRANTED
Friday, August 12, 2022SOU EXTENSION 2 FILED
Friday, August 12, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 15, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 15, 2022SOU EXTENSION 1 FILED
Tuesday, February 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 9, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 9, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 9, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 24, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 29, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 29, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION E-MAILED
Wednesday, May 19, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 11, 2021ASSIGNED TO EXAMINER
Tuesday, February 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 28, 2020NEW APPLICATION ENTERED

Related Keywords

dewpointx reagents research diagnostic laboratory development clinical drug purposes field discovery